*Vivimed Labs* engaged in research and manufacturing of active pharmaceutical ingredients and specialty chemicals announced a phenomenal rise in standalone net profit for the quarter ended December 2008. During the quarter, the profit of the company rose 58.59% to Rs 64.77 million from Rs 40.84 million in the same quarter previous year.
Net sales declined 17.01% to Rs 349 million, while total income for the quarter fell 17.06% to Rs 349.49 million, when compared with the prior year period. The company reported earnings of Rs 6.89 a share during the quarter, registering 58.76% growth over prior year period. *Quarterly Results - Standalone (Rs in mn)* *As at* *Dec - 08* *Dec - 07* *%Change* *Net Sales* 349.49 421.10 (17.01) *Net Profit* 64.77 40.84 58.59 *Basic EPS* 6.89 4.34 58.76 During the quarter, interest cost increased 2.53 times to Rs 32.47 million while depreciation cost fell 39.83% to Rs 4.94 million over previous year period. --~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
